AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17329690 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol D (18 seconds)
Number of subjects: 192
Study 17329690 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol E (21 seconds)
Number of subjects: 192
Study 15479169 — intervention group
Group type: EXPERIMENTAL
Intervention: bofu-tsusho-san (BF)
Number of subjects: 81
Study 15479169 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 81
Study 11398878 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 60
Study 11398878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 10517729 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (initial 30 mg intravenous bolus followed by 1.0 mg/kg every 12 hours; outpatient phase: 40 mg for patients <65 kg and 60 mg for patients ≥65 kg)
Number of subjects: 3910
Study 10517729 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) for ≥3 days followed by subcutaneous placebo injections
Number of subjects: 3910
Study 10517729 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 3910
Study 10517729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3910
Study 8584300 — intervention group
Group type: EXPERIMENTAL
Intervention: RGO‐II hybrid orthosis
Number of subjects: 21
Study 2127076 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake of 2.5 mmol/kg/day
Number of subjects: 24
Study 2127076 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake of 3.75 mmol/kg/day
Number of subjects: 24
Study 2127076 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake of 5 mmol/kg/day
Number of subjects: 24
Study 2127076 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate intake of 2.5 mmol/kg/day
Number of subjects: 24
Study 363977 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of clomipramine given three times a day
Number of subjects: 0
Study 363977 — intervention group
Group type: COMPARATOR
Intervention: 150 mg of clomipramine in a single bedtime dosage
Number of subjects: 0
Study 30531560 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered poster
Number of subjects: 990
Study 30531560 — intervention group
Group type: COMPARATOR
Intervention: CDC poster
Number of subjects: 990
Study 30531560 — intervention group
Group type: EXPERIMENTAL
Intervention: Both posters
Number of subjects: 990
Study 28681205 — intervention group
Group type: EXPERIMENTAL
Intervention: FM33.3 diet (33.3% fishmeal replaced by soy protein concentrate with 0.4% GMP)
Number of subjects: 0
Study 28681205 — intervention group
Group type: EXPERIMENTAL
Intervention: FM66.7 diet (66.7% fishmeal replaced by soy protein concentrate with 0.4% GMP)
Number of subjects: 0
Study 28681205 — intervention group
Group type: EXPERIMENTAL
Intervention: FM100 diet (100% fishmeal replaced by soy protein concentrate with 0.4% GMP)
Number of subjects: 0
Study 28681205 — intervention group
Group type: COMPARATOR
Intervention: FM0 diet (control diet with 0% fishmeal)
Number of subjects: 0
Study 28681205 — intervention group
Group type: EXPERIMENTAL
Intervention: FM diet groups (FM33.3 and FM66.7)
Number of subjects: 0
Study 28681205 — intervention group
Group type: EXPERIMENTAL
Intervention: FM diet groups with increasing FM replacement by SPC with GMP supplementation
Number of subjects: 0
Study 28681205 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing FM replacement level by SPC
Number of subjects: 0
Study 25897757 — intervention group
Group type: EXPERIMENTAL
Intervention: Aftercare coordination by phone (6 phone contacts at intervals of 2 weeks)
Number of subjects: 0
Study 25897757 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 25897757 — intervention group
Group type: EXPERIMENTAL
Intervention: Aftercare coordination by phone
Number of subjects: 0
Study 24029539 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term group therapy (80 weekly, 90 min sessions)
Number of subjects: 167
Study 24029539 — intervention group
Group type: COMPARATOR
Intervention: Short-term group therapy (20 weekly, 90 min sessions)
Number of subjects: 167
Study 21890888 — intervention group
Group type: EXPERIMENTAL
Intervention: rFVIIa (10 μg/kg)
Number of subjects: 40
Study 21890888 — intervention group
Group type: EXPERIMENTAL
Intervention: rFVIIa (20 μg/kg)
Number of subjects: 40
Study 21890888 — intervention group
Group type: EXPERIMENTAL
Intervention: rFVIIa (10 and 20 μg/kg)
Number of subjects: 40
Study 21890888 — intervention group
Group type: COMPARATOR
Intervention: rFVIIa (not specified dosage)
Number of subjects: 40
Study 19278128 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine polacrilex (6 mg)
Number of subjects: 0
Study 19278128 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 17184374 — intervention group
Group type: EXPERIMENTAL
Intervention: Repositioning every 2 hours in a lateral position and 4 hours in a supine position (experimental group)
Number of subjects: 235
Study 17184374 — intervention group
Group type: COMPARATOR
Intervention: Repositioning every 4 hours (control group)
Number of subjects: 235
Study 15250816 — intervention group
Group type: EXPERIMENTAL
Intervention: Manualized therapies
Number of subjects: 0
Study 15250816 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy process
Number of subjects: 0
Study 15250816 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical validation of change processes
Number of subjects: 0
Study 11930400 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0
Study 9776794 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of protein nutritional status (albumin and protein catabolic rate)
Number of subjects: 298
Study 8845601 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium augmentation (1700 mg)
Number of subjects: 101
Study 8845601 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) with dietary calcium augmentation
Number of subjects: 101
Study 8845601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 2521362 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 263
Study 2521362 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 263
Study 2521362 — intervention group
Group type: EXPERIMENTAL
Intervention: PTA
Number of subjects: 263
Study 2521362 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Surgery and PTA)
Number of subjects: 263
Study 2521362 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery after unsuccessful PTA
Number of subjects: 263
Study 1101946 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (2-Br-alpha-ergocryptine)
Number of subjects: 38
Study 1101946 — intervention group
Group type: COMPARATOR
Intervention: Chlorotrianisene
Number of subjects: 38
Study 31534042 — intervention group
Group type: EXPERIMENTAL
Intervention: Pandoravirus dulcis and Pandoravirus quercus
Number of subjects: 10
Study 31534042 — intervention group
Group type: COMPARATOR
Intervention: Comparative genomics of Pandoraviridae
Number of subjects: 10
Study 28119138 — intervention group
Group type: EXPERIMENTAL
Intervention: Kg‐Free intervention (10 weekly group sessions plus 2 booster fortnightly sessions, 2h30 each)
Number of subjects: 73
Study 28119138 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 73
Study 25938187 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and acceptance-based group therapy (MAGT)
Number of subjects: 69
Study 25938187 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group therapy (CBGT)
Number of subjects: 69
Study 23748166 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy for 8 months
Number of subjects: 119
Study 23748166 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity C-reactive protein (hs-CRP) levels
Number of subjects: 119
Study 23748166 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-CRP level
Number of subjects: 119
Study 22002336 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 43
Study 22002336 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan (300 mg)
Number of subjects: 43
Study 22002336 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren (300 mg)
Number of subjects: 43
Study 22002336 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan (300 mg) after 14 days
Number of subjects: 43
Study 22002336 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren (300 mg) after 14 days
Number of subjects: 43
Study 19426749 — intervention group
Group type: EXPERIMENTAL
Intervention: Central fixation point (FP)
Number of subjects: 0
Study 19426749 — intervention group
Group type: EXPERIMENTAL
Intervention: Surrounding fixation points (FPs)
Number of subjects: 0
Study 19426749 — intervention group
Group type: COMPARATOR
Intervention: No fixation point (FP)
Number of subjects: 0
Study 19426749 — intervention group
Group type: COMPARATOR
Intervention: Contrast discrimination task
Number of subjects: 0
Study 16466609 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 0.5 mg/2 mL bid
Number of subjects: 82
Study 16466609 — intervention group
Group type: COMPARATOR
Intervention: Disodium cromoglycate (DSCG) 20 mg/2 mL tid
Number of subjects: 82
Study 15385010 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcuff pediatric tracheal tube (HVLP cuff)
Number of subjects: 80
Study 15385010 — intervention group
Group type: COMPARATOR
Intervention: Mallinckrodt Hi-Contour P
Number of subjects: 80
Study 15385010 — intervention group
Group type: COMPARATOR
Intervention: Rüschelit Super Safety Clear
Number of subjects: 80
Study 15385010 — intervention group
Group type: COMPARATOR
Intervention: Sheridan CF
Number of subjects: 80
Study 11751715 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat
Number of subjects: 61
Study 11751715 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril
Number of subjects: 61
Study 9240180 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (weekly counselling 4-9 weeks after surgery)
Number of subjects: 50
Study 9240180 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 50
Study 8215266 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam
Number of subjects: 0
Study 8215266 — intervention group
Group type: COMPARATOR
Intervention: Ticarcillin-clavulanate
Number of subjects: 0
Study 2884059 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol
Number of subjects: 12
Study 2884059 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% carteolol
Number of subjects: 12
Study 2884059 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6% metipranolol
Number of subjects: 12
Study 2884059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31702409 — intervention group
Group type: EXPERIMENTAL
Intervention: CopeSmart mobile app used over a 4-week period
Number of subjects: 560
Study 31702409 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 560
Study 29914940 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT+PR (n=110)
Number of subjects: 219
Study 29914940 — intervention group
Group type: COMPARATOR
Intervention: Sham-IMT+PR (n=109)
Number of subjects: 219
Study 27938777 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM) intervention (maximum reward = $430)
Number of subjects: 140
Study 27938777 — intervention group
Group type: COMPARATOR
Intervention: Non-contingent yoked controls (NCYC)
Number of subjects: 140
Study 26700834 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete revascularization
Number of subjects: 203
Study 26700834 — intervention group
Group type: COMPARATOR
Intervention: IRA-only revascularization
Number of subjects: 203
Study 23123181 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement of both hands
Number of subjects: 22
Study 23123181 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery of the same movement
Number of subjects: 22
Study 23123181 — intervention group
Group type: COMPARATOR
Intervention: Instruction to hold both hands still
Number of subjects: 22
Study 22109763 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical ear peeling (CEP)
Number of subjects: 50
Study 22109763 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic/steroid treatment
Number of subjects: 50
Study 22109763 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical ear peeling (CEP) in chronic otitis externa exacerbation
Number of subjects: 50
Study 22109763 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical ear peeling (CEP) in acute otitis externa
Number of subjects: 50
Study 19947254 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblation-assisted tonsillectomy
Number of subjects: 92
Study 19947254 — intervention group
Group type: COMPARATOR
Intervention: Conventional dissection tonsillectomy
Number of subjects: 92
Study 17060250 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT training with supervision
Number of subjects: 20
Study 17060250 — intervention group
Group type: COMPARATOR
Intervention: CBT training without supervision (control group)
Number of subjects: 20
Study 17060250 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT training with continued supervision
Number of subjects: 20
Study 12577293 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligodendrogliomas
Number of subjects: 15
Study 12577293 — intervention group
Group type: COMPARATOR
Intervention: Low-grade oligodendrogliomas
Number of subjects: 15
Study 12577293 — intervention group
Group type: EXPERIMENTAL
Intervention: High-grade oligodendrogliomas
Number of subjects: 15
Study 10619946 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine drainage system with antibacterial device
Number of subjects: 213
Study 10619946 — intervention group
Group type: COMPARATOR
Intervention: Urine drainage system without antibacterial device
Number of subjects: 213
Study 9200094 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up visit at 4 weeks (FU)
Number of subjects: 100
Study 9200094 — intervention group
Group type: COMPARATOR
Intervention: No follow-up visit with instruction sheet (NFU)
Number of subjects: 100
Study 9200094 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall satisfaction with care
Number of subjects: 100
Study 8501455 — intervention group
Group type: EXPERIMENTAL
Intervention: Active placebos
Number of subjects: 0
Study 8501455 — intervention group
Group type: COMPARATOR
Intervention: Inert placebos
Number of subjects: 0
Study 3908509 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Goeckerman regimen with hydrocortisone valerate cream
Number of subjects: 19
Study 3908509 — intervention group
Group type: COMPARATOR
Intervention: Modified Goeckerman regimen with vehicle cream
Number of subjects: 19
Study 29680006 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraprostatic injections of onabotulinumtoxinA (200 U)
Number of subjects: 43
Study 29680006 — intervention group
Group type: COMPARATOR
Intervention: Cystoscopy only (Control)
Number of subjects: 43
Study 26117486 — intervention group
Group type: EXPERIMENTAL
Intervention: Unloader knee brace (adjusted)
Number of subjects: 29
Study 26117486 — intervention group
Group type: EXPERIMENTAL
Intervention: Unloader knee brace (unadjusted)
Number of subjects: 29
Study 26117486 — intervention group
Group type: COMPARATOR
Intervention: No brace
Number of subjects: 29
Study 24193238 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg (Group A)
Number of subjects: 106
Study 24193238 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group B)
Number of subjects: 106
Study 22692023 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk with Lactobacillus rhamnosus GG
Number of subjects: 523
Study 20879867 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand washing
Number of subjects: 90
Study 20879867 — intervention group
Group type: COMPARATOR
Intervention: Control (no hand washing)
Number of subjects: 90
Study 20879867 — intervention group
Group type: EXPERIMENTAL
Intervention: Households with index patients aged ≤8 years
Number of subjects: 90
Study 20879867 — intervention group
Group type: EXPERIMENTAL
Intervention: Households with secondary infections
Number of subjects: 90
Study 18573839 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES)
Number of subjects: 12
Study 18573839 — intervention group
Group type: COMPARATOR
Intervention: Healthy matched controls
Number of subjects: 12
Study 16095053 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial antigen stimulation (lipopolysaccharides or protein A)
Number of subjects: 61
Study 16095053 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 61
Study 12419751 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil alone (F)
Number of subjects: 416
Study 12419751 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil and mitomycin C (FM)
Number of subjects: 416
Study 12419751 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil, doxorubicin and mitomycin C (FAM)
Number of subjects: 416
Study 10599951 — intervention group
Group type: EXPERIMENTAL
Intervention: Deramciclane 10 mg
Number of subjects: 28
Study 10599951 — intervention group
Group type: EXPERIMENTAL
Intervention: Deramciclane 30 mg
Number of subjects: 28
Study 10599951 — intervention group
Group type: EXPERIMENTAL
Intervention: Deramciclane 60 mg
Number of subjects: 28
Study 10599951 — intervention group
Group type: EXPERIMENTAL
Intervention: Deramciclane (all doses)
Number of subjects: 28
Study 10599951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 7588688 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 days of heat acclimation
Number of subjects: 16
Study 7588688 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 days of heat acclimation
Number of subjects: 16
Study 7588688 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (normal light combat clothing)
Number of subjects: 16
Study 7588688 — intervention group
Group type: EXPERIMENTAL
Intervention: NBC protective clothing
Number of subjects: 16
Study 1945578 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP-PRP-T
Number of subjects: 112
Study 1945578 — intervention group
Group type: COMPARATOR
Intervention: DTP-Placebo
Number of subjects: 112
Study 6289447 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged course of chemotherapy (41 weeks) combining adriamycin, methotrexate in high doses followed by folinic acid, vincristine, and cyclophosphamide
Number of subjects: 156
Study 6289447 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy delivering 20 grays to the lungs
Number of subjects: 156
Study 6289447 — intervention group
Group type: EXPERIMENTAL
Intervention: Short course of chemotherapy (8 weeks) combining adriamycin, methotrexate in high doses, folinic acid and vincristine, associated with irradiation of the lungs
Number of subjects: 156
Study 31940095 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgaleal drains
Number of subjects: 150
Study 31940095 — intervention group
Group type: EXPERIMENTAL
Intervention: Curved incisions, larger craniotomy, and tumor size
Number of subjects: 150
Study 30784924 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinkeshu tablets
Number of subjects: 60
Study 30784924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 29326406 — intervention group
Group type: EXPERIMENTAL
Intervention: Visiting education (90 min) in the 1st week and smartphone application education (10 min) thrice a week in the 2nd and 3rd weeks
Number of subjects: 40
Study 29326406 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention details provided)
Number of subjects: 40
Study 25534369 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose tDCS
Number of subjects: 99
Study 25534369 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose tDCS
Number of subjects: 99
Study 25534369 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 99
Study 24708292 — intervention group
Group type: EXPERIMENTAL
Intervention: Luseogliflozin 2.5 mg
Number of subjects: 158
Study 24708292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study 23113543 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body hyperthermia combined with hyperthermic intraperitoneal chemotherapy
Number of subjects: 0
Study 23113543 — intervention group
Group type: COMPARATOR
Intervention: Oxaliplatin combined with 5-fluorouracil chemotherapy or Xeloda
Number of subjects: 0
Study 19778495 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive olanzapine (5 to 20 mg/d)
Number of subjects: 202
Study 19778495 — intervention group
Group type: COMPARATOR
Intervention: Adjunctive placebo
Number of subjects: 202
Study 17642422 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha2a (IFN) 5 mIU/m2 for 6 months
Number of subjects: 49
Study 17642422 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha2a (IFN) 5 mIU/m2 for 6 months plus lamivudine 4 mg/kg/day for 24 months
Number of subjects: 49
Study 17642422 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group III)
Number of subjects: 49
Study 15741208 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 557
Study 15741208 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporin A Microemulsion (CsA-ME)
Number of subjects: 557
Study 12421063 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual matching task with pictures of various objects and scenes
Number of subjects: 0
Study 12421063 — intervention group
Group type: EXPERIMENTAL
Intervention: Old-new recognition experiment using the same stimuli as the matching task
Number of subjects: 0
Study 10347354 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin composite cement
Number of subjects: 48
Study 10347354 — intervention group
Group type: COMPARATOR
Intervention: Compomer cement
Number of subjects: 48
Study 10347354 — intervention group
Group type: EXPERIMENTAL
Intervention: Crown type G (gold alloy)
Number of subjects: 48
Study 10347354 — intervention group
Group type: EXPERIMENTAL
Intervention: Crown type AC (bonding alloy)
Number of subjects: 48
Study 10347354 — intervention group
Group type: EXPERIMENTAL
Intervention: Crown type PC (porcelain)
Number of subjects: 48
Study 10347354 — intervention group
Group type: EXPERIMENTAL
Intervention: Crown type PS (porcelain)
Number of subjects: 48
Study 10347354 — intervention group
Group type: EXPERIMENTAL
Intervention: Method of cement removal
Number of subjects: 48